Abstract
Huntington disease (HD) is an autosomal dominant neurodegenerative disorder clinically characterized by the presence of choreiform movements, psychiatric sequelae, and dementia. While the majority (>90%) of HD patients become clinically symptomatic in adulthood, 5% to 10% of patients present with the juvenile-onset form of the disease, which is almost invariably associated with inheritance of the mutant allele from a symptomatic father. Unlike the adult-onset form of the disease, juvenile HD is generally characterized by the presence of progressive rigidity, seizures, ataxia, and dystonia.
Access provided by Autonomous University of Puebla. Download to read the full chapter text
Chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
References
Hug M, Hayden M. Huntington disease. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Potter NT, Spector EB, Prior TW. Technical standards and guidelines for Huntington disease. In: The American College of Medical Genetics Standards and Guidelines for Clinical Genetics Laboratories, Bethesda MD. Available at: http://www.acmg.net. Accessed February 17, 2003.
GeneTests [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Andrew SE, Goldberg YP, Theilman J, et al. A CCG repeat polymorphism adjacent to the CAG repeat in the Huntington disease gene: implications for diagnostic accuracy and predictive testing. Hum Mol Genet. 1994;3:65–67.
Margolis RL, Stine OC, Callahan C, et al. Two novel single-base-pairsubstitutions adjacent to the CAG repeat in the Huntington disease gene (IT15): implications for diagnostic testing. Am J Hum Genet. 1999;64:323–326.
Maher TA, Ito M, Loose BA, et al. Implementation of long PCR for the detection of very large trinucleotide repeat expansion in a 3-year-old with juvenile Huntington disease. Am J Hum Genet. 2002;71:552.
Bird TD. Hereditary ataxia overview. GeneReviews [database online]. Seattle: University of Washington. available at: http://www.genetests.org. Accessed January 7, 2003.
Potter NT, Nance MA, for the Ataxia Molecular Diagnostic Testing Group. Genetic testing for ataxia in North America. Mol Diagn. 2000;5:91–99.
Holmes SE, O’Hearn EE, McInnis MG, et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet. 1999;4:391–392.
Nakamura K, Jeong SY, Uchihara T, et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet. 2001;10:1441–1448.
Koob MD, moseley ML, Schut LJ, et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). Nat Genet. 1999;21:379–384.
Matsuura T, Yamagata T, Burgess DL, et al. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet. 2000;26:191–194.
Bidichandani SI, Ashizawa T. Friedreich ataxia. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Dorschner MO, Barden D, Stephens K. Diagnosis of five spinocerebellar ataxia disorders by multiplex amplification and capillary electrophoresis. J Mol Diagn. 2002;4:108–113.
Mao R, Aylsworth AS, Potter NT, et al. Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. Am J Med Genet. 2002;110:338–345.
Imbert G, Saudou F, Yvert G, et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nat Genet. 1996;14:285–291.
Snow K, Mao R. Extreme expansion detection in spinocerebellar ataxia type 2 and type 7. In: Potter NT, ed. Neurogenetics: Methods and Protocols. Vol. 217. Totowa, NJ: Humana Press; 2002:41–50.
Dalton JC, Day JW, Ranum LPW, et al. Spinocerebellar ataxia type 8. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Potter NT. Update on the genetics of ataxia. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed February 17, 2003.
Filla A, De Michelle G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996;59:554–560.
Potter NT, Miller CA, Anderson IJ. Mutation detection in an equivocal case of Friedreich ataxia. Pediatr Neurol. 2000;22:413–415.
Bird TD. Alzheimer overview. GeneReviews [database online]. Seattle: University of Washington. available at: http://www.genetests.org. Accessed January 7, 2003.
McKusick VA. Alzheimer disease (OMIM #104300). Online Mendelian Inheritance in Man [database online]. Baltimore: Johns Hopkins University. Available at: http://www.ncbi.nlm.nih.gov/omim/. Accessed January 7, 2003.
Third Wave Technologies. Apolipoprotein E (ApoE). L-0008. Madison, WI; 2002. Available at: http://www.twt.com. Accessed February 17, 2003.
Janssen JC, Beck JA, Campbell TA, et al. Early onset familial Alzheimer disease: mutation frequency in 31 families. Neurology. 2003;60:235–239.
Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson’s disease. Science. 1997;276:2045–2047.
Krüger R, Kuhn W, Müller T, et al. Ala30Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat Genet. 1998;18:106–108.
Mouradian MM. Recent advances in the genetics and pathogenesis of Parkinson disease. Neurology. 2002;58:179–185.
Brice A, Dürr A, Lücking C, et al. Parkin type of juvenile Parkinson disease. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Lücking CB, Brice A. Semiquantitative PCR for the detection of exon rearrangements in the parkin gene. In: Potter NT, ed. Neurogenetics: Methods and Protocols. Vol. 217. Totowa, NJ: Humana Press; 2002:13–26.
Leroy E, Boyer R, Auburger G, et al. The ubiquitin pathway in Parkinson’s disease. Nature. 1998;395:451–452.
Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science. 2003;299:256–259.
Le W-D, Xu P, Jankovic J, et al. Mutations in NR4A2 associated with familial Parkinson disease. Nat Genet. 2003;33:85–87.
Gaudette M, Saddique T. Amyotrophic lateral sclerosis overview. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 7, 2003.
Yang Y, Hentati A, Deng H-X, et al. The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive amyotrophic lateral sclerosis. Nat Genet. 2001;29:160–165.
Hadano S, Hand CK, Osuga H, et al. A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet. 2001;29:166–173.
deCarvalho Aguiar PM, Ozelius LJ. Classification and genetics of dystonia. Lancet Neurol. 2002;1:316–325.
Grotzsch H, Pizzolato G-P, Ghika J, et al. Neuropathology of a case of dopa-responsive dystonia associated with a new genetic locus, DYT14. Neurology. 2002;58:1839–1842.
Klein C, Ozelius LJ. Dystonia: clinical features, genetics, and treatment. Curr Opin Neurol. 2002;15:491–497.
Leung JC, Klein C, Friedman J, et al. Novel mutation in the Tor1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics. 2001;3:133–143.
Ozelius LJ, Hewett JW, Page CE, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat Genet. 1997;17:40–48.
Furukawa Y. Dopa-responsive dystonia. GeneReviews [database online]. Seattle: University of Washington. Available at: http://www.genetests.org. Accessed January 21, 2003.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Potter, N.T. (2007). Neurodegenerative Disorders. In: Leonard, D.G.B., Bagg, A., Caliendo, A.M., Kaul, K.L., Van Deerlin, V.M. (eds) Molecular Pathology in Clinical Practice. Springer, New York, NY. https://doi.org/10.1007/978-0-387-33227-7_15
Download citation
DOI: https://doi.org/10.1007/978-0-387-33227-7_15
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-33226-0
Online ISBN: 978-0-387-33227-7
eBook Packages: MedicineMedicine (R0)